You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Citation Tools

Article menu
Emerging technologies, pharmacology and therapeutics
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Weiss T, Yang L, Carr RD, et al
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
BMJ Open Diabetes Research and Care 2022;10:e002517. doi: 10.1136/bmjdrc-2021-002517